Direkt zum Inhalt
Merck

SEP040

Millipore

Seppro® IgY14

LC10

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352200
NACRES:
NA.32

Säule D × L

12.7 mm × 79.0 mm

Kapazität

12.5 mg total protein loading(178 μL of human plasma, average human protein conc 70 mg/mL)

Lagertemp.

2-8°C

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Seppro® IgY14-Säulen ermöglichen die Trennung von 14 hochabundanten Proteinen (HAP) aus Plasmaprotein-Mischungen. Die aviären polyklonalen IgY (Immunglobulin aus Eigelb)-Antikörper bieten aufgrund ihrer hochspezifischen Partitionierungseigenschaften wesentliche Vorteile gegenüber Konkurrenzprodukten, da den Forschern deutlich reinere humane Proteinmischungen zur Verfügung stehen. Darüber hinaus erleichtern Seppro®-Säulen Proteomanalysen am Plasmaproteom und sorgen für reinere Ergebnisse.

Abgereicherte Proteine:

Albumin
IgG
α1-Antitrypsin
IgA
IgM
Transferrin
Haptoglobin
α2-Macroglobulin
Fibrinogen
Komplement C3
α1-saures Glykoprotein (Orosomucoid)
HDL (Apolipoproteine A-I und A-II)
LDL (vorwiegend Apolipoprotein B)

Anwendung

Seppro IgY14, LC10 (Säulen mit 10 ml Bettvolumen) kann als Basis für die Entfernung von Plasma-/Serumprotein nach der Affinitätsentfernung von 14 hochabundanten Proteinen (HAP) aus humanen Plasmaproteingemischen mittels Flüssigkeitschromatographie verwendet werden. Seppro IgY14 wird unterstützend in der Analyse von niedrigabundanten Proteinen im humanen Serum/Plasma verwendet.

Rechtliche Hinweise

Seppro is a registered trademark of Merck KGaA, Darmstadt, Germany

Kit-Komponenten auch einzeln erhältlich

Produkt-Nr.
Beschreibung
SDB

  • S4199Seppro® Dilution bufferSDB

  • S4324Seppro® Stripping BufferSDB

  • S4449Seppro® Neutralization BufferSDB

  • CLS8163Corning® Costar® Spin-X® centrifuge tube filters, cellulose acetate membrane, pore size 0.45 μm, non-sterileSDB

Lagerklassenschlüssel

10 - Combustible liquids


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

  1. How does the storage temperature relate to shipping conditions?

    The storage conditions that a Sigma-Aldrich catalog and label recommend for products are deliberately conservative. For many products, long-term storage at low temperatures will increase the time during which they are expected to remain in specification and therefore are labeled accordingly. Where short-term storage, shipping time frame, or exposure to conditions other than those recommended for long-term storage will not affect product quality, Sigma-Aldrich will ship at ambient temperature. The products sensitive to short-term exposure to conditions other than their recommended long-term storage are shipped on wet or dry ice. Ambient temperature shipping helps to control shipping costs for our customers. At any time, our customers can request wet- or dry-ice shipment, but the special handling is at customer expense if our product history indicates that the product is stable for regular shipment. See Shipping and Storage for more information.

  2. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  3. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  4. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  5. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  6. My protein sample contains SDS.  Is this compatible with Product SEP040, Seppro® IgY14?  

    No. We do not recommend using protein samples containing SDS with Product No. SEP040. SDS is a detergent and would be expected to affect adversely the activity of the conjugated antibody in terms of depletion.

  7. How would I decide between Products SEP040, Seppro® IgY14 and PROT20LC, ProteoPrep® 20 Plasma Immunodepletion LC Columns?

    SEP040 is designed to deplete the top 14 abundant human proteins, while PROT20LC is designed to deplete the top 20 abundant human proteins. Also, all of the antibodies in SEP040 are IgY antibodies, while the PROT20LC antibodies and antibody ligands are primarily IgG-based.

  8. I originally purchased my Seppro IgY14 LC10 column from Genway.  Can I still contact Genway for technical support?

    All inquiries on the Seppro technology are now to be referred to Sigma-Aldrich. Customers should not contact Genway for technical assistance.

  9. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Nicole Haverland et al.
Journal of translational medicine, 8, 137-137 (2010-12-22)
Proteomic-based discovery of biomarkers for disease has recently come under scrutiny for a variety of issues; one prominent issue is the lack of orthogonal validation for biomarkers following discovery. Validation by ELISA or Western blot requires the use of antibodies
Tujin Shi et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(38), 15395-15400 (2012-09-06)
Sensitive detection of low-abundance proteins in complex biological samples has typically been achieved by immunoassays that use antibodies specific to target proteins; however, de novo development of antibodies is associated with high costs, long development lead times, and high failure
Yuan-Wan Sun et al.
Journal of proteome research, 18(9), 3461-3469 (2019-08-02)
We reported that breast density (BD) was inversely correlated with the plasma level of DHA in postmenopausal obese, but not in nonobese, women given Lovaza (n-3FA). To identify protein biomarkers for the possible differential effect of n-3FA on BD between
Chien-Lun Chen et al.
Journal of proteomics, 85, 28-43 (2013-05-02)
In this study, we evaluated the reproducibility of abundant urine protein depletion by hexapeptide-based library beads and an antibody-based affinity column using the iTRAQ technique. The antibody-based affinity-depletion approach, which proved superior, was then applied in conjunction with iTRAQ to
Majlinda Kullolli et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 939, 10-16 (2013-10-05)
Human plasma is a commonly used diagnostic fluid in clinical chemistry. In-depth plasma proteomic analysis is performed to search for disease biomarkers, however the large dynamic range of protein abundance in plasma presents a substantial analytical challenge. Removal of abundant

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.